Xenon Pharmaceuticals (XENE) P/E (2014 - 2026)
Xenon Pharmaceuticals (XENE) P/E from Nov 5, 2014 to Jul 21, 2026. The TTM Xenon Pharmaceuticals (XENE) P/E is -14.34. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Xenon Pharmaceuticals (XENE)
| Year | P/E | Change |
|---|---|---|
| 2026 | -14.34 | +42.21% |
| 2025 | -10.08 | -20.55% |
| 2024 | -12.69 | -24.25% |
| 2023 | -16.75 | -16.70% |
| 2022 | -20.11 | +15.27% |
| 2021 | -17.45 | -7.58% |
| 2020 | -18.88 | +116.55% |
| 2019 | -8.72 | +122.47% |
| 2018 | -3.92 | +120.93% |
| 2017 | -1.77 | -69.09% |
| 2016 | -5.74 | -165.62% |
| 2015 | 8.74 | -20.35% |
| 2014 | 10.98 | N/A |
Comparison Xenon Pharmaceuticals (XENE) P/E with competitors
Xenon Pharmaceuticals (XENE) P/E is -14.34.